SLAB Spacelabs Regs

RNS Number:5700T
Spacelabs Healthcare Inc.
23 March 2007


Spacelabs Healthcare Announces Launch of Two Diagnostic Cardiology Products


HAWTHORNE, CA -- (MARKET WIRE) -- March 23, 2007 -- Spacelabs Healthcare, Inc.
(LSE: SLAB), an international medical equipment company listed on the London AIM
market, announced today that its Healthcare Division, Spacelabs Healthcare, will
launch the evo Digital Holter Recorder and Voyager 12-Lead Electrocardiogram
("ECG") system at the American College of Cardiology's (ACC) 56th Annual
Scientific Session to be held in New Orleans, March 24-27, 2007.

The evo Digital Holter recorder is an advancement in digital Holter monitoring.
The recorder features a unique Dynamic Energy Source(TM) technology that ensures
that the evo is ready for use on the next patient, immediately following data
download. It also eliminates the need for disposable batteries. Small and
lightweight, evo can be concealed easily under patient clothing and offers 48
hours of recording time with pacer detection capability as well as an on-board
display to check signal quality.

The Voyager 12Ci high-end ECG system supports optimal workflow in high volume
ECG environments. It incorporates high quality 12-lead technology, intuitive
design, and advanced large color touch screen that displays patients' 12-lead
ECG in real-time. The system can acquire, interpret and store up to 120 ECG
records at any one time while also being able to print and send diagnostic ECG
reports to Spacelabs' recently launched Sentinel Cardiology Management System.

Deepak Chopra, Chief Executive Officer, Spacelabs Healthcare, stated, "Our
commitment to R&D since acquiring Del Mar Reynolds in July 2006 is exemplified
in our recent launch of the Sentinel Cardiology Management System and in today's
announcement of the launch of evo and Voyager. The ACC Session in New Orleans
will provide the perfect setting to highlight Spacelabs' dedication to next
generation Diagnostic Cardiology solutions that combine innovation with patient
comfort and ease of use for clinicians."

About Spacelabs Healthcare

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com) is an international
developer, manufacturer and distributor of medical equipment and services
including patient monitoring solutions, anesthesia delivery and ventilation
systems, diagnostic cardiology solutions and supplies and accessories selling to
hospitals, clinics and physicians offices. Additionally, the Company provides
ECG laboratory services to pharmaceutical companies undertaking clinical trials,
whereby patient ECG data is recorded analyzed, tabulated and interpreted.

The Company employs approximately 1,100 personnel in offices located in the UK,
Canada, India, France, Germany, Finland, Singapore and the United States.

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Such statements include information
regarding our expectations, goals or intentions about the future, including, but
not limited to, statements regarding the launch of the evo Digital Holter
Monitor and Voyager 12-Lead ECG system. The actual results may differ materially
from those described in or implied by any forward-looking statement. Other
important factors are set forth in our Securities and Exchange Commission
filings. All forward-looking statements speak only as of the date made, and we
undertake no obligation to update these forward-looking statements.

For Further Information:

Investor Contact
Jeremy Norton
Jnorton@osi-systems.com
310-717-9182

Media Contact
Dan Prueher
dan.prueher@spacelabs.com
608-695-5957

                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
PRLDXGDXUSDGGRD

Spacelabs Healthcare (LSE:SLAB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Spacelabs Healthcare (LSE:SLAB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024